Program Director

Dr. Todd Alexander

Dr. Todd Alexander is a Pediatric Nephrologist at the Stollery Children’s Hospital, the Canada Research Chair in Renal Epithelial Transport Physiology, and Professor in the Department of Pediatrics in the Department of Physiology at the University of Alberta. Dr. Alexander completed his MD at the University of Western Ontario. Training in Pediatrics was performed at Memorial University in Newfoundland and Pediatric Nephrology at the Hospital for Sick Children, Toronto. After this, he received a Ph.D. in Cell Biology from the University of Toronto. He completed a Post-doctoral fellowship in renal tubular physiology at St Radboud University in the Netherlands. The focus of Dr. Alexander’s research is primary transport mechanisms by which the renal tubule regulates the body’s electrolyte, and acid/base balance. In particular, he seeks to understand the molecular mechanisms responsible for altered tubular divalent cation reabsorption and their effects on calcium homeostasis; in particular how they cause childhood kidney stones. His work is supported by the Canadian Institute of Health Research, the Natural Sciences and Engineering Research Council, The Kidney Foundation of Canada, and the Women and Children’s Health Research Institute.

Curriculum Co-Chair

Dr. Adeera Levin

Dr. Levin is a Professor of Medicine, Head Division of Nephrology at the University of British Columbia, and Consultant nephrologist at Providence Health Care/ St Paul’s Hospital, in Vancouver Canada.

She is the Executive Director of the BC Renal Agency, which oversees the care, planning and budgets for Kidney services in the province of British Columbia

She is active in international activities across the spectrum of kidney activities, and has served as in leadership roles at the International Society of Nephrology (ISN), most recently as President ( 2015-17). She was one of the founding members of the Declaration of Istanbul Custodian Group (DICG), and served as one of the first Co-Chairs of that Group. She has been active in both ISN and DICG concerning advocacy for patient rights for equitable access to care, and in the prevention of exploitation of vulnerable populations.

Her major research interests include non-traditional risk factors for CVD in CKD patients,( with particular focus on anemia, phosphate and vitamin D, and progression of CKD variability) as well as models of care. She has over 300 peer reviewed publications, and numerous book chapters, and is the inaugural Editor-in-Chief of the new Canadian Journal of Kidney Health & Disease. She is the Principal Investigator on a large cohort study CAN-PREDDICT, and more recently, a large national SPOR network grant CAN-SOLVE CKD focusing on patient oriented research. She collaborates with investigators across Canada and internationally.

She has received numerous teaching and research awards from local and national groups. In 2013, she was awarded the Canadian Society of Nephrology Outstanding Contributions to Canadian Nephrology, and 2014 was awarded the Kidney Foundation Research Medal of Excellence, and inducted as a fellow into the Canadian Academy of Health Sciences. In 2015 she was awarded the Aubrey J Tingle Research Award for contributions to the province of BC; and, for her contributions to the life of Canadians, she was awarded the Order of Canada in 2015.

Curriculum Co-Chair

Dr. Sunny Hartwig

Dr. Sunny Hartwig

Dr. Sunny Hartwig is an Associate Professor in the Department of Biomedical Sciences, Atlantic Veterinary College, University of Prince Edward Island, a CIHR University Delegate and Member of the College, Royal Society of Canada. Dr. Hartwig completed her PhD at the Hospital for Sick Children, University of Toronto, in Renal Developmental Biology. She then completed a post-doctoral fellowship in Developmental Nephrology at Children’s Hospital Boston, Harvard Medical School. Dr. Hartwig’s research in the kidney is focused on the molecular regulation of nephrogenesis by members of the Sry-Related HMG Box (SOX) family of transcription factors. Dr. Hartwig's work is supported by The Kidney Foundation of Canada and CIHR.

The KRESCENT Program is a Strategic Training Program developed and supported by:


With additional generous support from:

AMGEN               Baxter Corporation               Merck-Frosst Canada Ltd.             Ortho Biotech              RocheShire BioChem Inc.

© 2005 The Kidney Foundation of Canada